Skip to main content
. 2016 May 11;8(6):1156–1166. doi: 10.1080/19420862.2016.1183083

Figure 5.

Figure 5.

Prophylactic efficacy of antibody 100F4 against the H5N8 NE14 or H5N6 SC14 virus in mice compared to oseltamivir treatment. (A) The time course of body weight changes. (B) The survival rate of different antibody and oseltamivir treatment groups when challenged with H5N8 NE14 strain. Survival rate was calculated as percent survival within each experimental group (n = 5 mice per group). (C) The time course of body weight changes. (D) The survival rate of different antibody and oseltamivir treatment groups when challenged with H5N6 SC14 strain. Survival rate was calculated as percent survival within each experimental group (n = 6 mice per group).